leisure time -WSS

leisure time

author：entertainment 2025-09-30 15:15:52 - browse：36

WICHITA, Kan. -- A second suspect is now in custody in connection with a mass shooting that injured nearly a dozen people earlier this month in Kansas, Wichita police announced Monday.

A 27-year-old man was arrested on suspicion of aggravated battery and possession of a firearm by a felon. On Friday, a 19-year-old man was arrested. It wasn't immediately clear if either man has been charged. Their names have not been released. A message left with Sedgwick County District Attorney Marc Bennett wasn't immediately returned.

The shooting happened in the early hours of July 2 at City Nightz in downtown Wichita. Nine people were shot and two others were trampled in the chaos that followed. No one died.

In addition to the arrests, police are searching for a 23-year-old man believed to have been involved in the shooting. A St. Louis-area man was arrested July 3, but prosecutors later determined he fired his gun to defend himself after shots were fired by two other men at the club.

The gunshot victims — seven men and two women — ranged in age from 22 to 34, police said. The two people trampled were a 30-year-old woman and a 31-year-old male.

Wichita is a city of nearly 400,000 people, located about 200 miles (320 kilometers) southwest of Kansas City, Missouri.

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Senate panel passes drug pricing bills, but drops one PBM reform

WSS

Virtual care provider acquires bankrupt Pear's prescription apps

Editas, Vertex strike deal on CRISPR

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

leisure time

leisure time

leisure time

How one medical school became remarkably diverse

Why health care costs have stayed mostly flat since 2010

In age of alternative facts, a scholarly course on calling out crap

Can medical device makers keep up in the race to treat obesity?

Tori Bowie and the unacceptable rates of Black maternal death

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Apple is now the first public company to be valued at $3 trillion

Medicare drug price negotiation hasn't dried up venture capital

Wildfire smoke exposes gaps in outdoor worker protections

Xenotransplantation trials will require adjusting expectations, experts say

focus

Violet CEO on training clinicians to promote more inclusive care

CRISPR gene editing developments we’re watching in 2024

Reanimated hearts work just as well for transplants, study finds

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Bispecific antibodies are next new thing in cancer immunotherapy

Inside the rise of 'mukbang' eating videos

focus

focus

entertainment

explore